FORTIS
← FORTIS
Politica

Is the United States on the verge of triggering a new influenza pandemic?

Renan Filho Por Renan Filho · 2026-11-05

As concerns mount over the spread of avian influenza among US livestock and the potential for human adaptation, political and public health experts question whether the current administration's response is adequate.

**Lead**

The question of whether America is inadvertently paving the way for a new flu pandemic has become a pressing political concern on both sides of the Atlantic. With the H5N1 strain of bird flu circulating widely in US dairy herds and sporadic human cases reported, experts warn that gaps in surveillance, vaccine production, and inter-agency coordination could allow the virus to gain a foothold in the human population. For the United Kingdom, which relies on global disease monitoring and has its own vulnerable poultry sector, the stakes could not be higher. The Biden administration, already navigating a fraught election year, must balance public health imperatives against agricultural lobbying and public fatigue with government mandates. The question is no longer merely scientific; it is fundamentally political.

**Context**

The current outbreak of highly pathogenic avian influenza among US cattle is unprecedented. Previously thought to be confined to birds, the virus's jump to mammals – and its subsequent spread among dairy farms – signals a worrying evolutionary step. While the immediate risk to the general public remains low, each infection in humans provides the virus an opportunity to adapt. The US Department of Agriculture and the Centers for Disease Control and Prevention have implemented some measures, including mandatory testing of lactating dairy cows before interstate movement. However, critics argue that these steps are reactive and insufficient. Political divisions over public health mandates, reminiscent of the Covid-19 pandemic, have hampered efforts to develop a comprehensive strategy. The Biden administration, facing a divisive election cycle, has been cautious in imposing restrictions that could be seen as government overreach. Meanwhile, the UK Health Security Agency has raised its own alert level and is closely monitoring the situation, particularly given the potential for the virus to reach British shores via migratory birds or global trade. The UK’s own poultry industry, already battered by post-Brexit trade frictions and cost-of-living pressures, would be devastated by a fresh outbreak. The British government has stockpiled antiviral drugs and is reviewing its vaccine contracts, but the pace of US decision-making remains a key variable in the equation.

Beyond the immediate epidemiological picture, the political landscape in Washington is deeply fractured. Vaccine scepticism, fuelled by a vocal minority in Congress and amplified by influential media figures, has made it difficult for public health officials to advocate for pre-emptive measures. Funding for pandemic preparedness, once a bipartisan priority, has become entangled in broader budget battles. The White House requested supplemental funding for bird flu response earlier this year, but the package remains stalled amid disagreements over immigration and border security. This gridlock mirrors the kind of institutional paralysis that experts had warned about after the Covid-19 crisis. The UK, though not immune to such political tensions, has a more centralised public health system and a less polarised media environment. Yet British officials know that a pandemic starting in the US would not respect national borders. The interlinked nature of travel, trade, and migratory bird patterns means that the UK cannot afford to be complacent.

**Analysis**

Why does this matter to the UK? Beyond the obvious public health implications, a US-triggered pandemic would have severe economic and diplomatic consequences. The UK's poultry industry, already struggling with post-Brexit trade barriers, would be devastated by a new outbreak. Moreover, the US is a key partner in global health security. A failure by Washington to contain a potential pandemic pathogen would erode trust in international cooperation. The current political climate in the US, marked by vaccine scepticism and resistance to public health measures, mirrors challenges seen in the UK during the early days of Covid-19. However, the UK has retained some of the pandemic preparedness infrastructure built during that crisis, such as the UKHSA and the Vaccine Taskforce. The question is whether these can be mobilised quickly enough if the US becomes an epicentre. The answer likely depends on political will – both in London and in Washington.

Yet the deeper concern is about transparency. During the early stages of the bird flu outbreak in US dairy cattle, there were delays in reporting genetic sequences to international databases. Such delays hinder global surveillance and allow the virus to spread silently. The World Health Organization has urged all countries to share data promptly. Political pressure from agricultural lobbies in the US may be influencing the speed and completeness of reporting. For British policy-makers, this is a reminder of the need to be self-reliant in pandemic preparedness while advocating for stronger global governance. The UK has historically been a leader in genomic surveillance, thanks to investments made during the Covid-19 pandemic. But that capacity needs constant maintenance. A new pandemic would test whether the UK’s political system has truly learned the lessons of the past.

**Sources**

This article draws on reports from the World Health Organization, the UK Health Security Agency, the US Centers for Disease Control and Prevention, and the Food and Agriculture Organization of the United Nations. Additional context from academic experts in virology and public health policy, as well as official statements from the UK Department for Environment, Food & Rural Affairs and the US Department of Agriculture.

Renan Filho
Sobre o autor
Renan Filho
Editor-Chefe do FORTIS News

Editor-chefe do FORTIS News. Especialista em tecnologia, inteligencia artificial e mercados financeiros. Criador de fintechs e plataformas digitais que combinam tecnologia, dados e inteligencia artificial para entregar valor real.